109 related articles for article (PubMed ID: 15693151)
21. Preoperative serum CA125 in surgical stage 1 epithelial ovarian cancer.
Obermair A
Gynecol Oncol; 2007 Nov; 107(2):357-8. PubMed ID: 17706272
[No Abstract] [Full Text] [Related]
22. Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care.
Parkin D; Cruickshank M
BJOG; 2010 Jul; 117(8):1033; author reply 1033-4. PubMed ID: 20536437
[No Abstract] [Full Text] [Related]
23. [Ovarian cancers and CA 125 in 2006].
Lambaudie E; Collinet P; Vinatier D
Gynecol Obstet Fertil; 2006 Mar; 34(3):254-7. PubMed ID: 16529967
[TBL] [Abstract][Full Text] [Related]
24. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
25. [Prevention and early detection of ovarian cancer].
Stummvoll W; Ruschitzka G
Gynakol Geburtshilfliche Rundsch; 1993; 33(2):125-8. PubMed ID: 8400907
[No Abstract] [Full Text] [Related]
26. Cancer antigen 125 and prognosis.
Høgdall E
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):4-8. PubMed ID: 18196998
[TBL] [Abstract][Full Text] [Related]
27. [Progress in the study of normal-sized ovary carcinoma syndrome].
Zeng DY; Shen J
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1149-51. PubMed ID: 16029582
[No Abstract] [Full Text] [Related]
28. The myth of measurable disease in ovarian cancer: revisited.
Markman M
Cancer Invest; 2009 Jan; 27(1):11-2. PubMed ID: 19160094
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous uroperitoneum and elevated Ca-125.
Li YX; Vaux K; Coleman P
Eur J Intern Med; 2008 Nov; 19(7):e47-8. PubMed ID: 19013362
[No Abstract] [Full Text] [Related]
30. Clinical problem-solving: hypereosinophilic syndrome.
Hassell LA
N Engl J Med; 1996 Feb; 334(8):539; author reply 540. PubMed ID: 8559221
[No Abstract] [Full Text] [Related]
31. Pelvic tuberculosis with elevated serum CA125: a diagnostic dilemma.
Jana N; Mukhopadhyay S; Dhali GK
J Obstet Gynaecol; 2007 Feb; 27(2):217-8. PubMed ID: 17454494
[No Abstract] [Full Text] [Related]
32. [Ovarian carcinoma: certain characteristics of evolution, advancement and diagnosis].
Prokopenko PG; Terent'ev AA
Vopr Onkol; 2009; 55(2):143-50. PubMed ID: 19514366
[No Abstract] [Full Text] [Related]
33. Characterization of serum biomarkers for detection of early stage ovarian cancer.
Kozak KR; Su F; Whitelegge JP; Faull K; Reddy S; Farias-Eisner R
Proteomics; 2005 Nov; 5(17):4589-96. PubMed ID: 16237736
[TBL] [Abstract][Full Text] [Related]
34. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
35. The role of regular physical examination in the detection of ovarian cancer recurrence.
Chan KK; Tam KF; Tse KY; Ngan HY
Gynecol Oncol; 2008 Aug; 110(2):158-61. PubMed ID: 18544459
[TBL] [Abstract][Full Text] [Related]
36. CA-125 as a biomarker for malignant transformation of endometriosis.
Check JH
Fertil Steril; 2009 May; 91(5):e35; author reply e36. PubMed ID: 19338996
[No Abstract] [Full Text] [Related]
37. Introducing the MUC16 gene: implications for prevention and early detection in epithelial ovarian cancer.
McLemore MR; Aouizerat B
Biol Res Nurs; 2005 Apr; 6(4):262-7. PubMed ID: 15788735
[TBL] [Abstract][Full Text] [Related]
38. [Pelvic tumor, elevated CA 125 level and tuberculosis].
Belletti GA; Millán AE; López A; Yorio MA; Jakob E; Bouchet D; Irico G
Medicina (B Aires); 2005; 65(2):181-2. PubMed ID: 16075819
[No Abstract] [Full Text] [Related]
39. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
[TBL] [Abstract][Full Text] [Related]
40. Reducing ovarian cancer death rates through screening.
Hartge P
Cancer; 2011 Feb; 117(3):449-50. PubMed ID: 21254048
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
